Conference Coverage

AES: Development of unobtrusive seizure-detection devices continues

Publish date: January 28, 2016

 

AT AES 2015

References

mzoler@frontlinemedcom.com

On Twitter @mitchelzoler

Pages

Recommended Reading

Medicolegal aspects of sleep apnea
MDedge Internal Medicine
Glutamate-based neuroimaging identifies epileptic foci
MDedge Internal Medicine
AES: Neurologists ignore low driving risk from epilepsy-drug withdrawal
MDedge Internal Medicine
AES: Hormonal contraceptives can boost seizures in epileptics
MDedge Internal Medicine
AES: Cannabidiol shows promising epilepsy safety and efficacy
MDedge Internal Medicine
AES: Many U.S. epilepsy patients receive suboptimal treatment
MDedge Internal Medicine
AES: Three studies show generic lamotrigine equals Lamictal
MDedge Internal Medicine
Good luck convincing patients that generics equal brand-name drugs
MDedge Internal Medicine
AES: Sparse evidence hints at epilepsy disease modification
MDedge Internal Medicine
AES: Seizure freedom attainable for most epilepsy patients
MDedge Internal Medicine